Dick Simon

Dick Simon is the co-founder and CEO of Sensorium Therapeutics, a drug discovery company which is translating insights from nature to develop novel FDA-approved medicines that address various mental health conditions. He is a serial entrepreneur and leader in advancing psychedelic-assisted therapies. He is the Chairman of the Advisory Council of Center for the Neuroscience of Psychedelics at Massachusetts General Hospital, co-founder and board member of the Boston Psychedelic Research Group and is on the steering committee for the Psychedelic Science Funders Collaborative.

After September 11, 2001, Dick co-founded and led the YPO Peace Action Network which leverages personal and business relationships, resources, and expertise for conflict resolution on local and global levels. Dick’s work has earned him YPO’s Global Humanitarian Award, Harvard Business School’s Making a Difference Award, inclusion in Real Leaders magazine’s “100 Visionary Leaders” and in the “100 Most Influential People in Psychedelics” list.